切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2018, Vol. 07 ›› Issue (02) : 138 -142. doi: 10.3877/cma.j.issn.2095-3232.2018.02.013

所属专题: 文献

临床研究

术后预后营养指数在肝细胞癌患者预后中的价值
梁荣朴1, 叶林森1, 张杰滨1, 汪国营1, 陈规划1,()   
  1. 1. 510630 广州,中山大学附属第三医院肝脏外科暨肝移植中心 中山大学器官移植研究所 广东省器官移植研究中心
  • 收稿日期:2017-11-18 出版日期:2018-04-10
  • 通信作者: 陈规划
  • 基金资助:
    广东省科技计划项目(2017B020209004,2017B020169013); 广州市科技计划项目(201604020001,2014B020228003,201508020262)

Value of postoperative prognostic nutritional index in prognosis of patients with hepatocellular carcinoma

Rongpu Liang1, Linsen Ye1, Jiebin Zhang1, Guoying Wang1, Guihua Chen1,()   

  1. 1. Department of Hepatic Surgery and Liver Transplantation Center, the Third Affiliated Hospital of Sun Yat-sen University; Organ Transplantation Institue of Sun Yat-sen Univesity; Organ Transplantation Research Center of Guangdong Province, Guangzhou 510630, China
  • Received:2017-11-18 Published:2018-04-10
  • Corresponding author: Guihua Chen
  • About author:
    Corresponding author: Chen Guihua, Email:
引用本文:

梁荣朴, 叶林森, 张杰滨, 汪国营, 陈规划. 术后预后营养指数在肝细胞癌患者预后中的价值[J]. 中华肝脏外科手术学电子杂志, 2018, 07(02): 138-142.

Rongpu Liang, Linsen Ye, Jiebin Zhang, Guoying Wang, Guihua Chen. Value of postoperative prognostic nutritional index in prognosis of patients with hepatocellular carcinoma[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2018, 07(02): 138-142.

目的

探讨术后预后营养指数(post-PNI)在肝细胞癌(肝癌)肝切除患者预后中的价值。

方法

回顾性分析2009年1月至2014年12月在中山大学附属第三医院行肝癌肝切除的316例患者临床资料。其中男289例,女27例;平均年龄(50±12)岁。患者均签署知情同意书,符合医学伦理学规定。采用患者术后第一次检查的ALB及淋巴细胞计数计算post-PNI。根据受试者工作特征(ROC)曲线确定post-PNI的最佳截断值,将患者分为高post-PNI组及低post-PNI组。两组生存分析采用Kaplan-Meier法和Log-rank检验,Cox比例风险模型评估生存预后的因素影响。

结果

ROC曲线决定post-PNI最佳截断值为36.4。高post-PNI组165例,低post-PNI组151例。高post-PNI组1、3、5年无复发生存率和总体生存率分别为74.4%、55.5%、50.3%和93.8%、85.9%、78.7%,低post-PNI组相应为60.9%、32.5%、27.1%和91.3%、72.0%、62.9%,差异有统计学意义(χ2=16.939,8.428;P<0.05)。多因素分析显示post-PNI≤36.4是肝癌肝切除患者无复发生存和总体生存的独立危险因素(HR=1.705,1.771;P<0.05)。

结论

post-PNI是肝癌肝切除患者无复发生存和总体生存的独立影响因素,低post-PNI患者预后差。

Objective

To explore the value of postoperative prognostic nutritional index (post-PNI) in the prognosis of patients with hepatocellular carcinoma (HCC) after hepatectomy.

Methods

Clinical data of 316 patients receiving HCC hepatectomy in the Third Affiliated Hospital of Sun Yat-sen University between January 2009 and December 2014 was analyzed retrospectively. There were 289 males and 27 females, with a mean age of (50±12) years. The informed consents of all patients were obtained and the local ethical committee approval was received. Post-PNI was calculated using value of ALB and lymphocyte count of the first examination after operation. The optimum cut-off value of post-PNI was defined according to receivers' operating characteristic (ROC) curve, and the patients were divided into high post-PNI group and low post-PNI group. Survival analysis of two groups was conducted using Kaplan-Meier method and Log-rank test, and the influencing factors for survival and prognosis were analyzed by Cox proportional hazard model.

Results

The optimum cut-off value of post-PNI was 36.4 by ROC curve. There were 165 cases in high post-PNI group, and 151 cases in low post-PNI group. The 1-, 3- and 5-year recurrence-free survival rate and overall survival rate of the high post-PNI group were respectively 74.4%, 55.5%, 50.3% and 93.8%, 85.9%, 78.7%, and were respectively 60.9%, 32.5%, 27.1% and 91.3%, 72.0% and 62.9% in low post-PNI group were, where significant differences were observed (χ2=16.939, 8.428; P<0.05). Multiple-factor analysis showed that post-PNI≤36.4 was the independent risk factor for the recurrence-free survival and overall survival of HCC hepatectomy patients (HR=1.705, 1.771; P<0.05).

Conclusions

Post-PNI is an influencing factor for the recurrence-free survival and overall survival of HCC hepatectomy patients. Low post-PNI patients have worse prognosis.

图1 316例肝癌肝切除患者术后预后营养指数的受试者工作特征(ROC)曲线图
图2 316例肝癌肝切除患者术后Kaplan-Meier生存曲线
表1 肝癌肝切除患者术后预后的Cox比例风险模型多因素分析
[1]
El-Serag HB. Hepatocellular carcinoma[J]. N Engl J Med, 2011, 365(12):1118-1127.
[2]
Zhong JH, Ma L, Li LQ. Postoperative therapy options for hepatocellular carcinoma[J]. Scand J Gastroenterol, 2014, 49(6):649-661.
[3]
Poon RT, Ng IO, Fan ST, et al. Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma:a study of a prospective cohort[J]. J Clin Oncol, 2001, 19(12):3037-3044.
[4]
Zhong JH, Li H, Li LQ, et al. Adjuvant therapy options following curative treatment of hepatocellular carcinoma:a systematic review of randomized trials[J]. Eur J Surg Oncol, 2012, 38(4):286-295.
[5]
Barreto Penié J, Cuban Group for the Study of Hospital Malnutrition. State of malnutrition in Cuban hospitals[J]. Nutrition, 2005, 21(4):487-497.
[6]
Andreoli A, De Lorenzo A, Cadeddu F, et al. New trends in nutritional status assessment of cancer patients[J]. Eur Rev Med Pharmacol Sci, 2011, 15(5):469-480.
[7]
Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients[J]. Nihon Geka Gakkai Zasshi, 1984, 85(9):1001-1005.
[8]
Jiang N, Deng JY, Ding XW, et al. Prognostic nutritional index predicts postoperative complications and long-term outcomes of gastric cancer[J]. World J Gastroenterol, 2014, 20(30):10537-10544.
[9]
Tokunaga R, Sakamoto Y, Nakagawa S, et al. Prognostic nutritional index predicts severe complications, recurrence, and poor prognosis in patients with colorectal cancer undergoing primary tumor resection[J]. Dis Colon Rectum, 2015, 58(11):1048-1057.
[10]
Feng JF, Chen QX. Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma[J]. Ther Clin Risk Manag, 2014(10):1-7.
[11]
Yao ZH, Tian GY, Wan YY, et al. Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma[J]. J Cancer Res Clin Oncol, 2013, 139(12):2117-2123.
[12]
Geng Y, Qi Q, Sun M, et al. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer[J]. Eur J Surg Oncol, 2015, 41(11):1508-1514.
[13]
Zhang X, Li C, Wen T, et al. Postoperative prognostic nutritional index predicts survival of patients with hepatocellular carcinoma within Milan criteria and hypersplenism[J]. J Gastrointest Surg, 2017, 21(10):1626-1634.
[14]
Omata M, Lesmana LA, Tateishi R, et al. Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma[J]. Hepatol Int, 2010, 4(2):439-474.
[15]
Chen KL, Liu YH, Li WY, et al. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type[J]. Ann Hematol, 2015, 94(8):1389-1400.
[16]
Watanabe M, Iwatsuki M, Iwagami S, et al. Prognostic nutritional index predicts outcomes of gastrectomy in the elderly[J]. World J Surg, 2012, 36(7):1632-1639.
[17]
Chan AW, Chan SL, Wong GL, et al. Prognostic nutritional index (PNI) predicts tumor recurrence of very early/early stage hepatocellular carcinoma after surgical resection[J]. Ann Surg Oncol, 2015, 22(13):4138-4148.
[18]
Ke M, Xu T, Li N, et al. Prognostic nutritional index predicts short-term outcomes after liver resection for hepatocellular carcinoma within the Milan criteria[J]. Oncotarget, 2016, 7(49):81611-81620.
[19]
Okamura Y, Sugiura T, Ito T, et al. The optimal cut-off value of the preoperative prognostic nutritional index for the survival differs according to the TNM stage in hepatocellular carcinoma[J]. Surg Today, 2017, 47(8):986-993.
[20]
Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting[J]. Immunity, 2004, 21(2):137-148.
[21]
Wu SJ, Lin YX, Ye H, et al. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy[J]. J Surg Oncol, 2016, 114(2):202-210.
[22]
Lin ZX, Ruan DY, Li Y, et al. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection[J]. World J Gastroenterol, 2015, 21(38):10898-10906.
[23]
Li X, Chen ZH, Xing YF, et al. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma[J]. Tumour Biol, 2015, 36(4):2263-2269.
[24]
Limaye AR, Clark V, Soldevila-Pico C, et al. Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma[J]. Hepatol Res, 2013, 43(7):757-764.
[1] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[2] 杨倩, 李翠芳, 张婉秋. 原发性肝癌自发性破裂出血急诊TACE术后的近远期预后及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 33-36.
[3] 王春荣, 陈姜, 喻晨. 循Glisson蒂鞘外解剖、Laennec膜入路腹腔镜解剖性左半肝切除术临床应用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 37-40.
[4] 栗艳松, 冯会敏, 刘明超, 刘泽鹏, 姜秋霞. STIP1在三阴性乳腺癌组织中的表达及临床意义研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 52-56.
[5] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[6] 张其坤, 商福超, 李琪, 栗光明, 王孟龙. 联合脾切除对肝癌合并门静脉高压症患者根治性切除术后的生存获益分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 613-618.
[7] 段文忠, 白延霞, 徐文亭, 祁虹霞, 吕志坚. 七氟烷和丙泊酚在肝切除术中麻醉效果比较Meta分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 640-645.
[8] 张文华, 陶焠, 胡添松. 不同部位外生型肝癌临床病理特点及其对术后肝内复发和预后影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 651-655.
[9] 唐灿, 李向阳, 秦浩然, 李婧, 王天云, 柯阳, 朱红. 原发性肝脏神经内分泌肿瘤单中心12例诊治与疗效分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 674-680.
[10] 张维志, 刘连新. 基于生物信息学分析IPO7在肝癌中的表达及意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 694-701.
[11] 叶文涛, 吴忠均, 廖锐. 癌旁组织ALOX15表达与肝癌根治性切除术后预后的关系[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 708-712.
[12] 卢艳军, 马健, 白鹏宇, 郭凌宏, 刘海义, 江波, 白文启, 张毅勋. 纳米碳在腹腔镜直肠癌根治术中253组淋巴结清扫的临床效果[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 473-477.
[13] 李永胜, 孙家和, 郭书伟, 卢义康, 刘洪洲. 高龄结直肠癌患者根治术后短期并发症及其影响因素[J]. 中华临床医师杂志(电子版), 2023, 17(9): 962-967.
[14] 王军, 刘鲲鹏, 姚兰, 张华, 魏越, 索利斌, 陈骏, 苗成利, 罗成华. 腹膜后肿瘤切除术中大量输血患者的麻醉管理特点与分析[J]. 中华临床医师杂志(电子版), 2023, 17(08): 844-849.
[15] 索利斌, 刘鲲鹏, 姚兰, 张华, 魏越, 王军, 陈骏, 苗成利, 罗成华. 原发性腹膜后副神经节瘤切除术麻醉管理的特点和分析[J]. 中华临床医师杂志(电子版), 2023, 17(07): 771-776.
阅读次数
全文


摘要